NUC-1031: Clinical Trials

3 trials of NUC-1031, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow NUC-1031: new trials by email Literature Review of NUC-1031 trials Research Report on NUC-1031

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers
Acelarin, Cisplatin - Biliary Tract Cancer, Gallbladder Cancer
Phase 1CompletedThe Christie NHS Foundation Trust212016-01-012023-05-17
Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer
Nuc-1031 and Carboplatin - Recurrent Ovarian Cancer
Phase 1CompletedImperial College Healthcare NHS Trust252014-11-012021-05-18
NUC-1031 in Patients With Advanced Solid Tumours
NUC-1031 - Cancer
Phase 1CompletedImperial College London682012-10-012024-03-20

Conditions studied

Biliary Tract Neoplasms (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Cholangiocarcinoma (1)  ·  Fallopian Tube Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)

Sponsors

Imperial College Healthcare NHS Trust (1)  ·  Imperial College London (1)  ·  The Christie NHS Foundation Trust (1)

Countries

United Kingdom (3)

Top investigators

Sarah Blagden, MBBS, MRCP (1)

Results publications

PMID 33210382

NIH funding

2014 (1), 2015 (1)